Polytopic vaccination with a live-attenuated dengue vaccine enhances B-cell and T-cell activation, but not neutralizing antibodies

Dengue, caused by dengue viruses (DENVs), is the most common arboviral disease of humans. Several dengue vaccine candidates are at different stages of clinical development and one has been licensed. Inoculation with live-attenuated DENV constructs is an approach that has been used by vaccine develop...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Heliyon
मुख्य लेखकों: Hunsawong, Taweewun, Wichit, Sineewanlaya, Phonpakobsin, Thipwipha, Poolpanichupatam, Yongyuth, Klungthong, Chonticha, Latthiwongsakorn, Napaporn, Thaisomboonsuk, Butsaya, Im-erbsin, Rawiwan, Yoon, In-Kyu, Ellison, Damon W., Macareo, Louis R., Srikiatkhachorn, Anon, Gibbons, Robert V., Fernandez, Stefan
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Elsevier 2017
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5367862/
https://ncbi.nlm.nih.gov/pubmed/28393119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.heliyon.2017.e00271
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन